检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

2022-RA-1074-ESGO AGO-OVAR 2.29 (ENGOT-ov34): atezolizumab in combination with bevacizumab and chemotherapy vs bevacizumab and chemotherapy in recurrent ovarian cancer

Philipp Harter,Frederik Marmé,Klaus Pietzner,Alexander Reuss,Isabelle Ray-Coquard,Andrés Redondo,Ana Oaknin, Goda Jonuskiene,Kristina Lindemann,Christian Kurzeder,Jens Huober,Els van Nieuwenhuysen,Stephanie Henry,Christian Marth,Irina Tsibulak,Nadin Cron,Patricia Pautier

Ovarian cancer（2022）

引用 0|浏览3
暂无评分
关键词
ovarian cancer,atezolizumab,chemotherapy,ago-ovar
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要